A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

Alistair S Hall; Beryl M Jackson; Amanda J Farrin; Maria Efthymiou; Julian H Barth; Joanne Copeland; Kristian M Bailey; Simon P R Romaine; Anthony J Balmforth; Terry McCormack; Andrew Whitehead; Marcus D Flather; Jane Nixon; SPACE ROCKET Trial Group; Gordon Murray

doi:10.1097/HJR.0b013e3283316ce8

A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

Alistair S Hall, Beryl M Jackson, Amanda J Farrin, Maria Efthymiou, Julian H Barth, Joanne Copeland, Kristian M Bailey, Simon P R Romaine, Anthony J Balmforth, Terry McCormack, Andrew Whitehead, Marcus D Flather, Jane Nixon, SPACE ROCKET Trial Group, Gordon Murray

Deanery of Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.

Original language	English
Pages (from-to)	712-21
Number of pages	10
Journal	European Journal of Preventive Cardiology
Volume	16
Issue number	6
DOIs	https://doi.org/10.1097/HJR.0b013e3283316ce8
Publication status	Published - 2009

Access to Document

10.1097/HJR.0b013e3283316ce8

http://cpr.sagepub.com/content/16/6/712

Fingerprint

Dive into the research topics of 'A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial'. Together they form a unique fingerprint.

MRC HUB NETWORK WORK
Murray, G.
MRC
1/01/09 → 31/08/15
Project: Research

Cite this

Hall, A. S., Jackson, B. M., Farrin, A. J., Efthymiou, M., Barth, J. H., Copeland, J., Bailey, K. M., Romaine, S. P. R., Balmforth, A. J., McCormack, T., Whitehead, A., Flather, M. D., Nixon, J., SPACE ROCKET Trial Group, & Murray, G. (2009). A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. European Journal of Preventive Cardiology, 16(6), 712-21. https://doi.org/10.1097/HJR.0b013e3283316ce8

@article{7f80884d61b4439a8242105b8800bfc0,

title = "A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial",

abstract = "We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.",

author = "Hall, {Alistair S} and Jackson, {Beryl M} and Farrin, {Amanda J} and Maria Efthymiou and Barth, {Julian H} and Joanne Copeland and Bailey, {Kristian M} and Romaine, {Simon P R} and Balmforth, {Anthony J} and Terry McCormack and Andrew Whitehead and Flather, {Marcus D} and Jane Nixon and {SPACE ROCKET Trial Group} and Gordon Murray",

year = "2009",

doi = "10.1097/HJR.0b013e3283316ce8",

language = "English",

volume = "16",

pages = "712--21",

journal = "European Journal of Preventive Cardiology",

issn = "2047-4873",

publisher = "SAGE Publications",

number = "6",

}

Hall, AS, Jackson, BM, Farrin, AJ, Efthymiou, M, Barth, JH, Copeland, J, Bailey, KM, Romaine, SPR, Balmforth, AJ, McCormack, T, Whitehead, A, Flather, MD, Nixon, J, SPACE ROCKET Trial Group & Murray, G 2009, 'A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial', European Journal of Preventive Cardiology, vol. 16, no. 6, pp. 712-21. https://doi.org/10.1097/HJR.0b013e3283316ce8

A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. / Hall, Alistair S; Jackson, Beryl M; Farrin, Amanda J et al.
In: European Journal of Preventive Cardiology, Vol. 16, No. 6, 2009, p. 712-21.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction

T2 - the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

AU - Hall, Alistair S

AU - Jackson, Beryl M

AU - Farrin, Amanda J

AU - Efthymiou, Maria

AU - Barth, Julian H

AU - Copeland, Joanne

AU - Bailey, Kristian M

AU - Romaine, Simon P R

AU - Balmforth, Anthony J

AU - McCormack, Terry

AU - Whitehead, Andrew

AU - Flather, Marcus D

AU - Nixon, Jane

AU - SPACE ROCKET Trial Group

AU - Murray, Gordon

PY - 2009

Y1 - 2009

N2 - We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.

AB - We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.

U2 - 10.1097/HJR.0b013e3283316ce8

DO - 10.1097/HJR.0b013e3283316ce8

M3 - Article

C2 - 19745745

SN - 2047-4873

VL - 16

SP - 712

EP - 721

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

IS - 6

ER -

Hall AS, Jackson BM, Farrin AJ, Efthymiou M, Barth JH, Copeland J et al. A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. European Journal of Preventive Cardiology. 2009;16(6):712-21. doi: 10.1097/HJR.0b013e3283316ce8

A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

Abstract / Description of output

Access to Document

Fingerprint

Projects

MRC HUB NETWORK WORK

Cite this